Lipid levels in the second year of life among HIV-infected and HIV-exposed uninfected Latin American children

AIDS

Volumn 26, Issue 2, 2012, Pages 235-240

  Hazra, Rohan ^a   Cohen, Rachel A ^b   Gonin, René ^b   Monteiro, Jacqueline P ^c   Hofer, Cristina B ^d   Negra, Marinella D ^e   Ruz, Noris P ^f  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WESTAT   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^f HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Antiretroviral; Cholesterol; Lipids; Pediatrics; Triglycerides

Indexed keywords

CHOLESTEROL; LAMIVUDINE; LIPID; LOPINAVIR PLUS RITONAVIR; PROTEINASE INHIBITOR; TRIACYLGLYCEROL; ZIDOVUDINE;

ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; JAMAICA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHOLESTEROL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERLIPIDEMIAS; INFANT; JAMAICA; LATIN AMERICA; MALE; PREVALENCE; TRIGLYCERIDES;

EID: 84155164079     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834dc5fc     Document Type: Article

References (12)

1. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al. Early antiretroviral therapy and mortality among HIVinfected infants. N Engl J Med 2008; 359:2233-2244.
2. Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach - 2010 revision. 2010.
3. Brewinski M, Megazzini K, Freimanis Hance L, Cruz MC, Pavia- Ruz N, Della Negra M, et al. Dyslipidemia in a cohort of HIVinfected Latin American children receiving highly active antiretroviral therapy. J Trop Pediatr 2011; 57:324-332.
4. Hazra R, Stoszek SK, Freimanis Hance L, Pinto J, Marques H, Peixoto M, et al. Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries. Int J Epidemiol 2009; 38:1207-1214.
5. WHO Anthro SAS Module. 2009.
6. Grunfeld C. Dyslipidemia and its treatment in HIV infection. Top HIV Med 18:112-118.
7. Tassiopoulos K, Williams PL, Seage GR 3rd, Crain M, Oleske J, Farley J. Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children. J Acquir Immune Defic Syndr 2008; 47:607-614.
8. Newman WP 3rd, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 1986; 314:138-144.
9. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 2001; 104:2815-2819.
10. Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics 2008; 122:198-208.
11. The Lipid Research Clinics Program prevalence study. Circulation 1980; 62:IV1-IV136.
12. Niinikoski H, Viikari J, Ronnemaa T, Lapinleimu H, Jokinen E, Salo P, et al. Prospective randomized trial of low-saturated-fat, low-cholesterol diet during the first 3 years of life. The STRIP baby project. Circulation 1996; 94:1386-1393.